BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor Meeting18-08-2022
18-08-2022
BIOCON LTD. - 532523 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting for FY 2021-2216-08-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor meeting10-08-2022
Biocon looks to shore up biosimilar business. Will its investment pay off?
Biological drugs are harvested from living organisms or certain components of living organisms. These drugs are very specific and highly effective as they are made inside or with the use of living cells. These help to cure complex diseases such as cancer and rheumatoid arthritis.09-08-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release titled 'Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility'.05-08-2022
SAT quashes insider trading charges against Biocon official Shreehas Tambe
The Securities Appellate Tribunal (SAT) has quashed the insider trading charges against Shreehas P Tambe when he was senior vice president of Biocon Ltd.04-08-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is further to our earlier letter dated July 28, 2022 regarding presentation and video recording of Q1 FY23 Earnings Call held on July 28, 2022, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-calltranscripts/# 1599024728333-3499b540-46d3.03-08-2022
BIOCON LTD. - 532523 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Biocon Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-07-2022
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results and scrutinizers' report of the 44th Annual General Meeting ('AGM') of the Company29-07-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement- Unaudited Financial Results for Quarter ended June 30, 2022 published in Financial Express (English Language- All India Edition) and Vijayavani (Kannada-Bengaluru Edition) on July 29, 2022.29-07-2022